Li, D., Fang, Y., Wu, L., Li, X., Fan, Y., Zhang, M., Guo, J., Yao, Y., Fang, J., Tang, K., Luo, F., Yu, Y., Min, X., Song, Z., Hu, J., Ma, R., Chen, Y., Zhang, V., Li, J., Liu, Y. (2026). Trastuzumab deruxtecan (T-DXd) in patients (pts) with
                    <i>HER2</i>
                    -mutant (HER2m) non-small cell lung cancer (NSCLC) and central nervous system (CNS) metastases (mets): Results from DESTINY-Lung05 (DL-05).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e20500